Clinical Trial Update: Desidustat in the Treatment of Anemia in CKD [Phase 3]

View source ↗

Summary

Phase 3 trial update for desidustat in treating anemia associated with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• Desidustat (Desidustat)

Snippet

Sponsor: Zydus Lifesciences Limited | Conditions: Chronic Kidney Disease Stage 3, Anemia | Phase 3 | Status: COMPLETED